Zura Bio Ltd
ZURA
NASDAQ
Biotechnology
$5.57
USD
-0.06 (-1.07%)
At close: Aug 14, 2026, 4:00 PM EDT
Market Cap $566.81M
Volume 793.5K
Revenue
$0
TTM
— YoY
Gross Margin
—
TTM
— YoY
Net Income
$-35.27M
TTM
-2.6%
YoY
Operating Cash Flow
$-37.76M
TTM
-128.8%
YoY
Revenue & Net Income
USD Millions
Margins Trend
Percent of revenue
Income Statement Detail
USD Millions, except per-share and share count figures
Metric | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | Q2 2026 |
|---|---|---|---|---|---|
Revenue | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
YoY Growth | — | — | — | — | — |
Cost of Revenue | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
Gross Profit | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
Selling, General & Administrative | 9.4 | 7.6 | 7.5 | 10.8 | 8.6 |
Other Operating Expenses | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
Total Operating Expenses | 18.1 | 19.5 | 18.4 | 25.5 | 29.3 |
Operating Income | -18.1 | -19.5 | -18.4 | -25.5 | -29.3 |
EBITDA | -18.1 | -19.5 | -18.4 | -25.5 | -29.3 |
Other Income / Expense | 0.4 | -0.0 | -0.0 | -0.0 | 1.0 |
Total Other Income / Expense | 2.1 | 1.5 | 1.2 | 1.3 | 2.9 |
Income Before Income Taxes | -16.0 | -18.0 | -17.2 | -24.2 | -26.4 |
Income Taxes | 0.0 | 0.0 | 0.0 | 0.0 | -0.1 |
Net Income | 17.4 | -18.0 | -17.2 | -24.2 | 24.2 |
Consolidated Net Income / Loss | -16.0 | -18.0 | -17.2 | -24.2 | -26.3 |
Net Income Attributable to Common Shareholders | -16.0 | -20.0 | -45.9 | -24.2 | -26.3 |
Basic EPS | -$0.17 | -$0.21 | -$0.48 | -$0.22 | -$0.21 |
Diluted EPS | -$0.17 | -$0.21 | -$0.48 | -$0.22 | -$0.21 |
Basic Shares Outstanding | 94.3M | 94.6M | 94.8M | 112.2M | 126.8M |
Diluted Shares Outstanding | 94.3M | 94.6M | 94.8M | 112.2M | 126.8M |